Investing

Top Active Trader Alert Stocks (AVNR, HGSI, JASO, LDSH, RINO)

Active traders and day traders have many stocks to choose from this Wednesday morning.  We are tracking news and moves in shares of Avanir Pharmaceuticals (NASDAQ: AVNR), Human Genome Sciences, Inc. (NASDAQ: HGSI), JA Solar Holdings, Co., Ltd. (NASDAQ: JASO), Ladish Co., Inc. (NASDAQ: LDSH), and Rino International (NASDAQ: RINO).

Avanir Pharmaceuticals (NASDAQ: AVNR) is down premarket on light volume. The Company announced it would be releasing a public stock option.

Human Genome Sciences, Inc. (NASDAQ: HGSI) is down almost 6% after being downgraded by Citi and Bank Of America.

JA Solar Holdings, Co., Ltd. (NASDAQ: JASO) Is down 2.68% to $7.64, relative to a 52-week range of $3.70-$10.24.

Ladish Co., Inc. (NASDAQ: LDSH) is going through the roof after the announcement that the company would be acquired by Allegheny Technologies.

Rino International (NASDAQ: RINO) is on our list for the second in as many days. sustaining heavy losses after it was announced that the company would be investigated for their financial statements.

 

 

 

 

 

100 Million Americans Are Missing This Crucial Retirement Tool

The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.

Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.

A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.

Click here to learn how to get a quote in just a few minutes.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.